Ranger™ and Ranger™ SL (OTW) DCB) in China

Clinical trial NCT02944071 · COMPLETED

Trial details

NCT number: NCT02944071
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Femoropopliteal Artery Lesions

Start date: 2016-11-24
Primary completion: 2020-12-22
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.